The Bottom Line
One connected source of truth for R&D finance
Condor is an enterprise-grade platform that automates the entire R&D finance workflow, from accruals and forecasting to vendor management and close, with a proprietary financial data model co-developed with Big 4 accounting firms. If you need a benchmark report, Auxilius is an option. If you need your finance team to stop living in spreadsheets and start operating with real-time intelligence, Condor is the platform.
AI purpose-built for life sciences
Not a horizontal tool configured for pharma — Condor is architected from the ground up for pipeline economics and the unique forecasting challenges of drug development.
Enterprise-grade. Compliance by design. Audit-ready.
Founded by an EY auditor. Built with the Big 4 to establish clinical trial finance best practices. Every output is traceable, explainable, and defensible — your team owns the numbers.
Trusted by the best in biopharma
Trusted by accounting, FP&A, and clinical operations teams at Menarini Group, Acadia Pharmaceuticals, Alumis Therapeutics, BridgeBio Pharma, and Madrigal Pharmaceuticals. Customers report 90%+ forecast accuracy, 70% faster month-end close, and up to 30% budget savings.
Capability Comparison
Condor vs. Auxilius
AI-Powered Financial Intelligence Technology for Life Sciences
FP&A and accounting workbook and managed services for clinical trials
Clinical trial accruals
Automated, audit-ready
Managed services-dependent
Vendor reconciliation
Automated across CROs and sites
Manual, consultant-supported
Budget vs. actual tracking
Real-time across all programs
Periodic, manual assembly
Month-end close
Day 0-3 close
Managed services-dependent
Rolling forecast
90%+ accuracy
Not a primary offering
ERP, EDC, and CTMS integration
Native, automated data flows
No true integration
Big 4 validated data model
Co-developed with Big 4
X
Compliance and audit support
SOX controls embeddedn
Managed-service dependent
AI-Powered
Clinical Finance Ontology, SMART Data Ingestion
X
Product vision
Agentic Experience across Accruals, Forecasting, Budgeting/Benchmarking
X
Clinical trial accruals
Automated, audit-ready
Managed services-dependent
Vendor reconciliation
Automated across CROs and sites
Manual, consultant-supported
Budget vs. actual tracking
Real-time across all programs
Periodic, manual assembly
Month-end close
Day 0-3 close
Managed services-dependent
Rolling forecast
90%+ accuracy
Not a primary offering
ERP, EDC, and CTMS integration
Native, automated data flows
No true integration
Big 4 validated data model
Co-developed with Big 4
X
Compliance and audit support
SOX controls embeddedn
Managed-service dependent
AI-Powered
Clinical Finance Ontology, SMART Data Ingestion
X
Product vision
Agentic Experience across Accruals, Forecasting, Budgeting/Benchmarking
X
What Condor does
Replace manual reconciliation with real-time financial clarity
01
Protocol-driven accruals
Expenses recognized based on the clinical protocol schedule and real EDC data — not CRO tracker estimates. Most teams using services-based tools never get operational-driver accruals properly configured and default to CRO estimates instead. Condor makes the right approach the default.
$750K–$1.25M earlier financial insight per program
02
Amendment & change order visibility
Surfaces pending protocol changes and budget amendments before contracts close. Accrue against expected changes to smooth quarter-end spikes and avoid audit questions.
$750K–$1.25M forecast accuracy improvement
03
Automated data reconciliation
SMART Mapping automatically ingests and reconciles data across EDC, CTMS, ERP, and investigator payment systems — eliminating multi-day manual reconciliation cycles every close.
$300K–$500K annual efficiency improvement
04
Scenario planning & forecasting
Condor is the clear leader in dynamic scenario modeling. Model the impact of adding sites, accelerating enrollment, adjusting timelines, or expanding geographies — and answer the CFO’s “what if” in the meeting, not two days later by email.
$750K–$1.25M optimization potential per $25M trial
05
Compliance by design
Built on a proprietary clinical and financial data standard co-developed with EY, KPMG & PwC. Every output is traceable, explainable, and defensible — audit-ready by default, not by effort.
Co-developed with EY, KPMG & PwC
06
Total value delivered
Across a typical $25M clinical program, Condor delivers measurable financial impact. Customers report 90%+ forecast accuracy, 70% faster month-end close, and 30% average budget savings.
$2M–$3M per clinical program
R&D Finance Maturity Model
Where does your team stand?
Your trials are growing. Your spreadsheet is not. As your portfolio scales, finance, accounting, and clinical operations cannot stay aligned on a patchwork of manual files. The right solution depends on where you need to be — not just where you are today.
Level 1
Workbook / Spreadsheet
Level 2
Managed services workbook
Level 3
Financial intelligence
Trusted by leading biopharma
Built for CFOs. Trusted by accounting, FP&A, and clinical operations.
Accuracy
0
%
+
Forecast accuracy reported by Condor customers
Performance
0
%
Faster month-end close for finance teams on Condor
Savings
0
%
Average budget savings reported by customers
Scale
$
0
B+
In R&D spend managed on Condor today
How is Condor different from other clinical trial finance tools?
What makes Condor trustworthy for audit and compliance purposes?
Does Condor handle the full R&D finance workflow, or just accruals?
How do we know if Condor is a good fit for our company?
- Your finance team spends 30-40% of close doing manual reconciliation
- Your CFO is making program decisions without real-time spend visibility
- You are growing your trial portfolio faster than your team can scale
- Your current accruals process relies on spreadsheets your auditors question
- You are preparing for an IPO, partnership, or regulatory submission and need audit-grade financials